Showing results (861-870 of 991) with videos related to

Sort By:
Pageof 100
Blood Advances|June 30, 2026
Validation of the newly introduced Deauville Score 5a in patients treated for advanced-stage classic Hodgkin LymphomaSimon Leiders, Dominic Ufton, Helen Kaul, et al.
Gastrointestinal Endoscopy|May 9, 2022
Longitudinal assessment of colonoscopy adverse events in the prospective Cooperative Studies Program no. 380 colorectal cancer screening and surveillance cohortElizabeth A Kobe, Brian A Sullivan, Xuejun Qin, et al.
NPJ Precision Oncology|June 7, 2018
<i>ALK</i><sup>G1269A</sup> mutation as a potential mechanism of acquired resistance to crizotinib in an <i>ALK</i>-rearranged inflammatory myofibroblastic tumorSebastian Y F Michels, Andreas H Scheel, Thomas Wündisch, et al.
JACC. Advances|October 28, 2025
Traditional and HIV-Specific Risk Factors Associated With Atrial Fibrillation Among Underrepresented Minority Groups With HIVElizabeth A Kobe, Robert M Clare, Karen Chiswell, et al.
JTO Clinical and Research Reports|June 30, 2022
Efficacy of Immune Checkpoint Inhibitor With or Without Chemotherapy for Nonsquamous NSCLC With Malignant Pleural Effusion: A Retrospective Multicenter Cohort StudyHayato Kawachi, Motohiro Tamiya, Yoshihiko Taniguchi, et al.
Journal of Cancer Research and Clinical Oncology|October 29, 2022
More than one-third of advanced non-small-cell lung cancer patients do not receive immunochemotherapy due to intoleranceChihiro Ando, Eiki Ichihara, Toshihide Yokoyama, et al.
Neurobiology of Disease|June 9, 2019
Mild hypothermia ameliorates anesthesia toxicity in the neonatal macaque brainChrysanthy Ikonomidou, George Kirvassilis, Brant S Swiney, et al.
Hemasphere|November 15, 2019
Reduced-Intensity Chemotherapy in Patients With Advanced-Stage Hodgkin Lymphoma: Updated Results of the Open-Label, International, Randomised Phase 3 HD15 Trial by the German Hodgkin Study GroupAndreas Engert, Helen Goergen, Jana Markova, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2009
Downregulation of 18F-FDG uptake in PET as an early pharmacodynamic effect in treatment of non-small cell lung cancer with the mTOR inhibitor everolimusLucia Nogová, Ronald Boellaard, Carsten Kobe, et al.
Structure (London, England : 1993)|December 19, 2017
Structural and Functional Characterization of a Cross-Reactive Dengue Virus Neutralizing Antibody that Recognizes a Cryptic EpitopeJie Li, Daniel Watterson, Chiung-Wen Chang, et al.
Pageof 100